European Biotechnology Magazine

The Leadership Edit Thumbnail European Biotechnology

Sensorion names CMO; Orano Med adds CSO; CRISPR Therapeutics changes CFO

Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us about the companies they join. This week: a hearing-loss specialist adds clinical … more ➔

allogeneic CAR-T

Roche scraps off-the-shelf CAR-T from Poseida deal worth up to $1.5B

Switzerland’s Roche has discontinued RG6540, an experimental off-the-shelf CAR-T therapy targeting the CD19 and CD20 proteins, less than two years after agreeing to acquire its developer, Poseida Therapeutics, … more ➔

Photo by National Cancer Institute via Unsplash+

cancer immunotherapy

Menarini adds Georgiamune’s oral immunotherapy candidate to its solid-tumor portfolio for $45M upfront

Italy’s Menarini Group will pay Maryland biotech Georgiamune $45 million (€40 million) in upfront and near-term payments, in a deal worth up to $1.1 billion (€1.0 billion) plus royalties, for worldwide … more ➔

M&A

Qiagen agrees to go private with €10.8B takeover by EQT

Swedish private equity firm EQT wants to acquire diagnostics specialist Qiagen for €10.8 billion, or €46.50 per share. The company’s leadership unanimously supports the sale. Completion is planned … more ➔

Alzheimer’s Disease

Muna’s oral Alzheimer’s candidate shifts age-associated markers in Phase 1

An experimental oral drug for early Alzheimer’s disease has produced positive Phase 1 results, including shifts in spinal-fluid markers of brain immune activity and neuronal stress in older volunteers … more ➔

European Biotechnology

1 / 4

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

Get a free sample copy | Abo

2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

Get a free sample copy | Abo

3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

Get a free sample copy | Abo

4 / 4

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

Get a free sample copy | Abo

Stay up to date with the biotech industry!

Once a week, european-biotechnology.com brings you up to date on the latest developments in the biotech industry. In our free newsletter, you will find the latest news from business, research and politics, as well as lots of useful information and job vacancies.

Subscribe to our free newsletter!Subscribe here

autoimmune disease

Arctic Therapeutics raises $21.5M to take autoimmune programs to clinic

Icelandic biotech Arctic Therapeutics has raised $21.5 million (€19.1 million) in an oversubscribed round to take two drug candidates for autoimmune disease toward the clinic. more ➔

Meanwhile in biotech

Evaxion reports durable responses; Novartis halts kidney trial; AstraZeneca signs AI deal

Beyond the main headlines, European biotech kept moving this week. This edition of Meanwhile in Biotech covers cancer vaccine follow-up, changes to kidney and obesity trials, and two developments in … more ➔

APPOINTMENTS

all appointments

Qiagen

EVENT

November 3 @ 09:00 - 13:00in Heidelberg, Germany

IP Seminar for Life Sciences & Chemistry

How can pharmaceutical, biotech and chemical companies effectively protect innovation in a rapidly evolving European patent landscape? BOEHMERT & BOEHMERT's complimentary IP Seminar in Heidelberg explores recent developments at the Unified Patent Court (UPC), the Unitary Patent system and the European Patent Office, highlighting practical strategie ... ➔

Sensorion names CMO; Orano Med adds CSO; CRISPR Therapeutics changes CFO

Roche scraps off-the-shelf CAR-T from Poseida deal worth up to $1.5B

Menarini adds Georgiamune’s oral immunotherapy candidate to its solid-tumor portfolio for $45M upfront

Qiagen agrees to go private with €10.8B takeover by EQT

Muna’s oral Alzheimer’s candidate shifts age-associated markers in Phase 1

European Biotechnology

NEWSLETTER

Stay up to date with the biotech industry!

Arctic Therapeutics raises $21.5M to take autoimmune programs to clinic

Evaxion reports durable responses; Novartis halts kidney trial; AstraZeneca signs AI deal

Sponsored Publications

Closing AI medicine’s manufacturing gap

From development to commercial reality

Europe’s CGT advantage at risk

APPOINTMENTS

New CEO took over the reins

Samanta Cimitan to (re)join Lonza from Celonic

Clinical Development Expert has started

ADC expert appointed as CEO

Ambrose expands rare disease pipeline with €161M AM-Pharma acquisition

$15 billion deal: Roche bets on China — and questions Germany’s future

Merck to buy siRNA specialist Silence Therapeutics for $1.3 billion

EVENT

IP Seminar for Life Sciences & Chemistry

Stay up to date every week with the european biotechnology newsletter.

Stay up to date every week with the european biotechnology newsletter.

European Biotechnology

NEWSLETTER

Stay up to date with the biotech industry!

Sponsored Publications

EVENT

IP Seminar for Life Sciences & Chemistry